June 1, 2016 – Eos Biosciences will attend the 2016 Biotechnology Innovation Organization (BIO) International Convention being held June 6 – 9, 2016, in San Francisco. Eos Biosciences’ Chief Executive Officer, Omar Haffar, Ph.D. and Chief Financial Officer, Thomas Plotts will attend the BIO International Convention.
Recent Posts
- Eos Biosciences Issued Patent for New Approach to Shuttle Therapeutics Across the Blood‐Brain Barrier to Treat Brain Diseases March 20, 2019
- Eos Biosciences will attend the 2018 Biotechnology Innovation Organization (BIO) International Convention in Boston, June 2-5, 2018 May 15, 2018
- Eos Biosciences Announces Issuance of Additional U.S. Patent For Targeted Breast Cancer Therapy October 17, 2017
- Eos Biosciences Announces Issuance of U.S. Patent for Novel Oncology Theranostic September 13, 2017
- Eos Biosciences will attend the 2017 Biotechnology Innovation Organization (BIO) February 10, 2017